Service Development Resources
-
SACT Board Good Practice Guidance for Immuno-Oncology Medicines
The UK Systemic Anti-Cancer Treatment (SACT) board has updated in guidance on immuno-oncology medications in collaboration with the IOCN. This document is designed to give a practical framework for the safe introduction and ongoing use of immuno-oncology in existing SACT services.
-
Building an immuno-oncology service and the questions to consider
Dr Olsson-Brown's powerpoint on points and vital questions to review when building an IO service.
-
Immunotherapy Service Impact - The Clatterbridge Cancer Centre Liverpool
The impact of an immuno-oncology service at a regional cancer centre based in the north west of the UK, published in the British Journal of Nursing.